PhD student Kennedy Michael Ngowi supervised by Dr Marion Sumari-de Boer (CDF972 - The REMIND Study) wins best Abstract @ ICASA 2019 - Congratulations!
PhD student Kennedy Michael Ngowi supervised by Dr Marion Sumari-de Boer (CDF972) wins best Abstract @ ICASA 2019 - Congratulations!
Track B: Clinical Science, Treatment and Care
Abstract Title: Real Time Medication Monitoring improves virological outcome among People Living with HIV on Antiretroviral Treatment in Moshi, Tanzania
For more details view http://www.icasa2019rwanda.org/abstracts/best-abstract-awards.html
Europe PubMed Central Training Webinar 16 March 2021
EDCTP has become a member of Europe PMC (PubMed Central), an open science platform that maintains a worldwide collection of scientific articles and research outputs. Joining Europe PMC enables EDCTP-funded researchers to share their publications via one central location. Sharing publications by EuropePMC ensures that they will also satisfy the requirements for EDCTP-funded research projects: making publications openly accessible as soon as possible. EDCTP invites all EDCTP grantees to attend a training webinar on 16 March at 09:00 UTC. This webinar will introduce the EDCTP open access policy and provide step-by-step guidance on how to comply with the policy and deposit research manuscripts using the Europe PMC plus submission system for inclusion in Europe PMC and PMC USA.
Click here for more information.
Congratulations to Dr Faith Osier who has taken over as the President of the International Union of Immunological Societies
As of October 2019, Dr Faith Osier (TMA2015SF1001) is the president of the International Union of Immunological Societies (https://iuis.org/about/who-we-are/executive-council/) for a three year term.
The International Union of Immunological Societies (IUIS) is an umbrella organization for many of the regional and national societies of immunology throughout the world. As articulated in its Constitution, the objectives of IUIS are:
Dr Osier was also recently appointed as a #TOGETHERBAND Amasssador for the United Nations Sustainable Development Goal 3: Good Health & Well Being.
This week Dr Osier gave a Spotlight talk at the Grand Challenges meeting held in Addis Ababa, Ethiopia.
Congratulations on these great career acheivements!
Call for Experts − WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases Deadline: 16 July 2022
The World Health Organization (WHO) is seeking experts to serve as members of the Strategic and Technical Advisory Group for Neglected Tropical Diseases. This “Call for Experts” notice provides information about the advisory group in question, the expert profiles being sought, the process to express interest, and the process of selection.
The Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) is the main advisory body to World Health Organization in this field.
NTDs are a diverse set of bacterial, viral, parasitic, fungal and noncommunicable diseases and disease groups that disproportionately affect populations living in poverty, predominantly in tropical and subtropical areas. Twenty diseases and disease groups are currently included in the NTD portfolio, and currently more than one billion people are affected.
STAG-NTD advises and makes policy and strategic recommendations to WHO, based on independent reviews of progress made and challenges faced by programmes and partners, with the aim of facilitating the achievement of the targets and milestones set by the NTD road map 2021–2030.
In its capacity as an advisory body to WHO, the STAG-NTD shall have the following functions:
The STAG-NTD will normally meet in person once a year at WHO Headquarters in Geneva, Switzerland, usually for 2-3 days. Depending on the issues at stake, additional interim meetings may be organized in the course of the year. The working language of the STAG-NTD will be English.
The STAG-NTD will be multidisciplinary, with members having a range of technical knowledge, skills and experience relevant to NTDs and of the challenges faced by programmes and partners within the context of health systems in NTD-endemic countries. Up to approximately 20 members may be selected.
WHO welcomes expressions of interest from individuals with knowledge, skills and experience in:
To register your interest in being considered for the [name of the advisory group], please submit the following documents by 24:00h (midnight) Geneva time on 16 July 2022 to aimel@who.int using the subject line “Expression of interest for the STAG-NTD”.
After submission, your expression of interest will be reviewed by WHO. Due to an expected high volume of interest, only selected individuals will be informed.
Members of WHO advisory groups (AGs) must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of an AG is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).
All AG members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts (https://www.who.int/about/ethics/declarations-of-interest). AG members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.
At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant AG.
The selection of members of the AG will be made by WHO in its sole discretion, taking into account the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations .The selection of AG members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.
If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of an AG will be subject to the proposed member returning to WHO the countersigned copy of these two documents.
WHO reserves the right to accept or reject any expression of interest, to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO's action. WHO may also decide, at any time, not to proceed with the establishment of the AG, disband an existing AG or modify the work of the AG.
WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.
WHO may publish the names and a short biography of the selected individuals on the WHO internet.
AG members will not be remunerated for their services in relation to the AG or otherwise. Travel and accommodation expenses of AG members to participate in AG meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.
The appointment will be limited in time as indicated in the letter of appointment.
If you have any questions about this “Call for experts”, please write to aimel@who.int well before the applicable deadline.